Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Cash from Discontinued Operations (2022 - 2023)

Firefly Neuroscience has reported Cash from Discontinued Operations over the past 2 years, most recently at 693106.0 for Q1 2023.

  • Quarterly results put Cash from Discontinued Operations at 693106.0 for Q1 2023, up 2.09% from a year ago — trailing twelve months through Dec 2023 was 693106.0 (down 125.72% YoY), and the annual figure for FY2023 was 693106.0, down 141.49%.
  • Cash from Discontinued Operations for Q1 2023 was 693106.0 at Firefly Neuroscience, down from 4001468.0 in the prior quarter.
  • Over the last five years, Cash from Discontinued Operations for AIFF hit a ceiling of 4001468.0 in Q4 2022 and a floor of 707876.0 in Q1 2022.